Nurix Therapeutics (NRIX) Current Leases (2021 - 2025)
Historic Current Leases for Nurix Therapeutics (NRIX) over the last 5 years, with Q4 2025 value amounting to $2.8 million.
- Nurix Therapeutics' Current Leases fell 6476.17% to $2.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was $2.8 million, marking a year-over-year decrease of 6476.17%. This contributed to the annual value of $2.8 million for FY2025, which is 6476.17% down from last year.
- Nurix Therapeutics' Current Leases amounted to $2.8 million in Q4 2025, which was down 6476.17% from $3.8 million recorded in Q3 2025.
- In the past 5 years, Nurix Therapeutics' Current Leases ranged from a high of $8.0 million in Q4 2024 and a low of $2.8 million during Q4 2025
- Its 5-year average for Current Leases is $5.8 million, with a median of $5.5 million in 2022.
- Per our database at Business Quant, Nurix Therapeutics' Current Leases skyrocketed by 4374.84% in 2022 and then crashed by 6476.17% in 2025.
- Quarter analysis of 5 years shows Nurix Therapeutics' Current Leases stood at $3.8 million in 2021, then skyrocketed by 43.75% to $5.5 million in 2022, then surged by 35.42% to $7.5 million in 2023, then increased by 7.01% to $8.0 million in 2024, then tumbled by 64.76% to $2.8 million in 2025.
- Its Current Leases stands at $2.8 million for Q4 2025, versus $3.8 million for Q3 2025 and $5.2 million for Q2 2025.